Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 2: Treatment, progress and outcome.
A controlled longitudinal prospective study is reported of physical and neuropsychological progress up to 12 years in 152 children with congenital hypothyroidism (CH), detected by newborn screening in the Australian state of Victoria and born between the onset of screening in mid-1977 and December 1988. Linear growth of the CH children was normal. Throughout they were slightly heavier and the median head circumference was slightly larger compared with reference data. Those with thyroid aplasia required a marginally larger dose of thyroxine to achieve euthyroidism. Assessment of cognitive outcome in the children with permanent primary CH revealed the mean scores at 2, 5 and 8 years to be from 8.5 (p<0.001) to 10.2 (p<0.001) points lower than in a group of 60 euthyroid controls. However, there was large overlap and, of the affected children, only 10.1% at 2 years, 3.9% at 5 years and 6.8% at 8 years fell more than 2 SD below the means of the euthyroid controls. On univariate analysis, variables shown to have significant correlation with cognitive outcome at 8 years in the CH children were newborn activity, baseline TT4 and FTI, initial T4 dosage, socio-economic classification, maternal age, maternal education and presence of a serious accompanying disorder. On multiple regression analysis, significant variables were baseline bone age, maternal age and education, and presence of a serious accompanying disorder. No single thyroidal or extra-thyroidal variable could be identified to account for the discrepancy between the children with CH and the controls.
Connelly
J F
JF
Department of Clinical Biochemistry, Royal Children 's Hospital, Parkville, Victoria, Australia. connelly@labyrinth.net.au
Rickards
A L
AL
Coakley
J C
JC
Price
G J
GJ
Francis
I
I
Mathur
K S
KS
Wolfe
R
R
D000365:Age Determination by Skeleton; D000886:Anthropometry; D001315:Australia; D002657:Child Development; D003071:Cognition; D003409:Congenital Hypothyroidism; D018450:Disease Progression; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy*; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology / Q000628:therapy*; D008137:Longitudinal Studies; D008297:Male; D008403:Mass Screening; D009483:Neuropsychological Tests; D011446:Prospective Studies; D011932:Reading; D016896:Treatment Outcome